FDA Inspection 1225221 — BioReliance Limited

BioReliance Limited — FEI 3005619544

The FDA completed an inspection of BioReliance Limited on November 7, 2023 in Penicuik. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Penicuik (United Kingdom)